Abiopharma

🔍 Shine Sarah (Executive)

Company: ERIE INDEMNITY CO (ERIE)

Report Date: 2026-04-30

Detailed Transactions and Holdings:

• Acquired 9 shares of Class A Common Stock at $218.93 per share (Direct)
  Date: 2026-04-30 | Code: J | equity_swap_involved: 0 | shares_owned_after: 547.28 | transaction_form_type: 4 | Footnotes: F1
• Holds 2,694 shares of Incentive Compensation Deferral Plan Share Credits (Derivative)
  Date: 2026-04-30 | Code: H | shares_owned_after: 2,693.80 | Footnotes: F2, F3, F3

Footnotes:

• F1: Participant directed transaction under 401(k) Plan.
• F2: Conversion price is not applicable to shares granted under the Erie Indemnity Company Incentive Compensation Deferral Plan.
• F3: The shares subject to this reporting are Share Credits which are periodically credited to the accounts of a select group of management and highly compensated employees of Erie Indemnity Company pursuant to its Incentive Compensation Deferral Plan. These Share Credits represent the right to receive an equivalent number of shares of Erie Indemnity Company Class A common stock when the reporting individual retires or otherwise separates from service with the Company. There are no exercisable or expiration dates for these securities.